Effect of Erythropoietin Therapy on Lipogram in Chronic Haemodialysis Patients
IHAB EL-SAYED GODA;
Abstract
Cardiovascular disease (CVD) is a major cause of morbidity and mortality in patients with all forms of chronic kidney disease (CKD).
Cardiovascular disease accounts for 40% to 50% of deaths in dialysis populations. Overall, the risk of cardiac mortality
Cardiovascular disease accounts for 40% to 50% of deaths in dialysis populations. Overall, the risk of cardiac mortality
Other data
| Title | Effect of Erythropoietin Therapy on Lipogram in Chronic Haemodialysis Patients | Other Titles | تأثير العلاج بالاريثروبيوتين على دهنيات الدم فى مرضى الفشل الكلوى المزمن الذين يعالجون بالاستصفاء الدموى | Authors | IHAB EL-SAYED GODA | Keywords | Effect of Erythropoietin Therapy on Lipogram in Chronic Haemodialysis Patients | Issue Date | 2009 | Description | Cardiovascular disease (CVD) is a major cause of morbidity and mortality in patients with all forms of chronic kidney disease (CKD). Cardiovascular disease accounts for 40% to 50% of deaths in dialysis populations. Overall, the risk of cardiac mortality |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| Binder1.pdf | 219.33 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.